Enabling next generation digital transformation, Elitecore Technologies, (a Sterlite Technologies Company), a global provider of Next-generation BSS and Packet Core solution, has won two major customer implementations in Southeast Asia with its end-to-end Convergent, Real time, Pre-integrated MVNE/O platform enabling rapid service delivery & customer care to meet pertinent growth aspects of MVNE/O such as Revenue Generation, Service Differentiation & Cost Optimization.
Dhaval Vora, VP, Product Management, Elitecore Technologies comments– “These two wins are a great start for us in becoming a leading MVNE/O solution provider in Southeast Asia, where the MVNO market is growing at a rapid pace. With the end-to-end multi-tenant platform, Elitecore MVNE/O solution offers reduced TCO and flexibility to monetize and personalize user experience.”
The first win comes with a leading Tier-1 operator to build an MVNE infrastructure enabling multi-brand strategy and multiple MVNOs on the same stack. The multi-tenant highly scalable platform supports complete data segregation capability with high data integrity and security that allows on-boarded MVNOs to have full personalization & control via self-care channels. MVNOs have the flexibility to design and offer their own plans and offers with customized branding on all their customer interface such as invoice, web and mobile self-care app, payment receipt etc.
The second success comes with an MVNO, using mobile network of a leading Tier-1 operator to launch prepaid and post-paid voice, data and messaging services for its customers on 3G/4G network. Elitecore solution is a compact pre-integrated platform with out-of-box support for all MVNO business journey.
Elitecore MVNE/O solution supports multiple business units/joint ventures/MVNOs on the same stack. The platform includes Core Network access (AAA, PCRF, DPI), convergent real-time charging, Convergent Prepaid Post-paid billing, centralized product catalog, CRM, Campaign Management, loyalty retention and Self-care via web, mobile and IVR.